Antibody News and Research

RSS

An antibody is a blood protein that is produced in response to and counteracts an antigen. Antibodies are produced in response to disease and help the body fight against the particular disease. In this way, antibodies help the body develop an immunity to disease.

Rare case of COVID-19 vaccine-induced hypophysitis in a woman with central diabetes insipidus manifestations

A new study to be published in the Therapies journal aimed to analyze a rare case of hypophysitis caused by pituitary stalk thickening three days following the administration of the SARS-CoV-2 vaccine.

11 Oct 2022

Evaluating graphene field effect biosensor for ultraprecise and simultaneous influenza and SARS-CoV-2 detection

In a new study, researchers developed an antibody (Ab)-modified graphene field effect transistor (GFET)-based biosensor for ultraprecise and rapid influenza A virus (IAV) and SARS-CoV-2 protein detection and differentiation.

10 Oct 2022

Scientists explore kinetics of naturally induced anti-SARS-CoV-2 antibodies in the Kenyan population

In a new study, researchers investigated the breadth and longevity of immunity induced by natural severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) exposure among the Kenyan population.

10 Oct 2022

New class of drugs can safely counter allergic asthma without creating vulnerability to infections

Blocking the action of calcium signals in immune cells suppresses the most common form of asthma, but without compromising the body's defenses against flu viruses, a new study finds.

7 Oct 2022

Study evaluates efficacy of a candidate SARS-CoV-2 subunit vaccine to protect endangered black-footed-ferrets

In a new study, researchers assessed the safety, efficacy, and immunogenicity of a candidate SARS-CoV-2 subunit vaccine in black-footed ferrets (BFF), and investigated the susceptibility of these endangered North American mammals to the virus.

7 Oct 2022

Vaccine-induced neutralizing and non-neutralizing antibody activity against SARS-CoV-2

A new study demonstrated that vaccine-induced antibody functions against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) diminish with age.

7 Oct 2022

Study suggests an immunological benefit of combining previous natural infection with vaccination against COVID-19 using a combination of different vaccine platforms

Researchers explored SARS-CoV-2-targeted immune responses among COVAC1 participants who received a novel saRNA vaccine followed by the mRNA BNT162b2 vaccine BNT162b2 vaccine, with or without prior COVID-19 history.

7 Oct 2022

Scientists investigate the antibody titers post-mRNA COVID-19 booster vaccine in the elderly

The coronavirus 2019 disease (COVID-19) pandemic has affected millions worldwide and claimed multiple lives.

6 Oct 2022

Clinical trials of novel COVID-19 vaccine developed in Brazil to begin soon

Testing on humans of a novel COVID-19 vaccine developed in Brazil will begin this year. It performed well in animal trials, as reported in an article published in August in Nature Communications.

6 Oct 2022

Novel protein vaccine NVX-CoV2373 triggered functional T cell responses to SARS-CoV-2

Researchers determined the T cell response to the NVX-CoV2373, an adjuvanted recombinant full-length SARS-CoV-2 spike (S) trimer protein vaccine.

5 Oct 2022

PSI researchers optimize a method for tumor diagnosis using radionuclides

Researchers at the Paul Scherrer Institute PSI, in collaboration with ETH Zurich, have optimized a method for tumor diagnosis using radionuclides.

5 Oct 2022

Omicron reduces host antibody response by lower B-cell antigenicity

A new study explores the functional relevance of some Omicron mutations in terms of their ability to escape neutralizing antibody responses.

4 Oct 2022

Antibody escape mutations of SARS-CoV-2 BA.2.75

A new study discusses how immune escape mutations allow a recent SARS-CoV-2 variant to evade neutralizing antibodies and cause breakthrough infections.

4 Oct 2022

Comparative immunogenicity of COVID-19 vaccines in North California

In new research, researchers evaluated vaccine responses among North Californian residents, including differences in vaccine side effects and antibody (Ab) titers by age, sex, and vaccine type.

4 Oct 2022

Spike-specific memory B cells develop resilience to SARS-CoV-2

In a recent study posted to the bioRxiv* preprint server, researchers explored the cross-reactivity, avidity, and kinetics of memory B-cells and serum antibodies in vaccinated and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infected individuals.

4 Oct 2022

Antibody News and Research

Further Reading

Rare case of COVID-19 vaccine-induced hypophysitis in a woman with central diabetes insipidus manifestations

Evaluating graphene field effect biosensor for ultraprecise and simultaneous influenza and SARS-CoV-2 detection

Scientists explore kinetics of naturally induced anti-SARS-CoV-2 antibodies in the Kenyan population

New class of drugs can safely counter allergic asthma without creating vulnerability to infections

Study evaluates efficacy of a candidate SARS-CoV-2 subunit vaccine to protect endangered black-footed-ferrets

Vaccine-induced neutralizing and non-neutralizing antibody activity against SARS-CoV-2

Study suggests an immunological benefit of combining previous natural infection with vaccination against COVID-19 using a combination of different vaccine platforms

Scientists investigate the antibody titers post-mRNA COVID-19 booster vaccine in the elderly

Clinical trials of novel COVID-19 vaccine developed in Brazil to begin soon

Novel protein vaccine NVX-CoV2373 triggered functional T cell responses to SARS-CoV-2

PSI researchers optimize a method for tumor diagnosis using radionuclides

Omicron reduces host antibody response by lower B-cell antigenicity

Antibody escape mutations of SARS-CoV-2 BA.2.75

Comparative immunogenicity of COVID-19 vaccines in North California

Spike-specific memory B cells develop resilience to SARS-CoV-2

A case for updating COVID vaccines with beta variant spike sequences

Researchers report aminoadamantanes that block SARS-CoV-2 infection by S-nitrosylation of the host ACE2 protein

The duration of the infectious stage of individuals infected with the SARS-CoV-2 Omicron variant

COVID-19 vaccination offers sustained and potent neutralizing protection against variants compared to natural infection

Universal vaccine advancement through AI and recombinant technology

Using single B cell screening to boost antibody discovery eBook

Latest eBooks

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Advancing degrader and proximity-based drug development

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo